3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
13
Phase 1/2
2
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma
10
Leukemia
10
Myelodysplastic Syndromes
9
Multiple Myeloma
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Congenital Abnormalities
9
Lymphoma, Follicular
8
Hodgkin Disease
8
Recurrence
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
7
Primary Myelofibrosis
6
Neoplasms, Plasma Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Myeloid, Chronic-Phase
6
Burkitt Lymphoma
6
Blast Crisis
6
Myeloproliferative Disorders
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Myeloid, Accelerated Phase
5
Dendritic Cell Sarcoma, Interdigitating
5
Polycythemia Vera
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Thrombocythemia, Essential
3
Interventions
Cyclosporine
4
fludarabine phosphate
3
Mycophenolic Acid
3
Cyclophosphamide
3
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Cord Blood Stem Cell Transplantation
2
pegaspargase
1
Vincristine
1
Thioguanine
1
Therapeutics
1
Specimen Handling
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pentetic Acid
1
Oxycodone
1
Ondansetron
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Mitoxantrone
1
Minocycline
1
Methotrexate
1
Methadone
1
Mercaptopurine
1
Melphalan
1
Massage
1
Leucovorin
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Biphenotypic, Acute
×
Busulfan
×
Clear all
NCT00550992
2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA
Unknown
445 enrolled